Featured
Zanubrutinib may be poised to challenge ibrutinib for CLL
Hematology News
The Bruton tyrosine kinase (BTK) inhibitor zanubrutinib appears safe and effective for patients with B-cell malignancies, according to results from a phase 1 trial.
Latest News
August 22, 2019
Oncologists agree with AI treatment decisions about half the time
August 22, 2019
MDedge Hematology and Oncology
August 21, 2019
Combo produces responses in triple-class refractory myeloma
August 21, 2019
MDedge Hematology and Oncology
August 21, 2019
Adding chemo beats standard gefitinib for EGFR-mutated lung cancer
August 21, 2019
MDedge Hematology and Oncology
From the Editor
Dr. Matt Kalaycio tackles challenges in academic leadership and current controversies in the specialty.
Hard Questions
Dr. Ilana Yurkiewicz explores the human side of hematology, sharing patient encounters in her hem-onc fellowship.
How I Will Treat My Next Patient
Dr. Alan Lyss breaks down the latest study findings into practice-changing tips.
Conference Coverage
August 12, 2019
Ibrutinib/rituximab effective, safe as frontline treatment for older patients with MCL
August 12, 2019
MDedge Hematology and Oncology
August 9, 2019
HDAC/HMA combo shows ‘remarkable’ activity in PTCL
August 9, 2019
MDedge Hematology and Oncology
August 8, 2019
Beyond sunscreen: Skin cancer preventive agents finding a role
August 8, 2019
MDedge Hematology and Oncology
Drug Approvals
August 16, 2019
New transfusion guidelines for thalassemia
August 16, 2019
MDedge Hematology and Oncology
August 16, 2019
FDA approves fedratinib for myelofibrosis
August 16, 2019
MDedge Hematology and Oncology
August 2, 2019
FDA approves Turalio for symptomatic tenosynovial giant cell tumor
August 2, 2019
MDedge Hematology and Oncology
July 31, 2019
HHS proposes pathways for drug importation
July 31, 2019
MDedge Hematology and Oncology
Policy & Practice
August 21, 2019
Forging a path for gender equality in medicine
August 21, 2019
MDedge Hematology and Oncology
August 20, 2019
Unsubsidized enrollees leaving insurance exchanges
August 20, 2019
MDedge Hematology and Oncology
August 19, 2019
ACP unveils clinical guideline disclosure strategy
August 19, 2019
MDedge Hematology and Oncology
August 16, 2019
Legal duty to nonpatients: Driving accidents
August 16, 2019
MDedge Hematology and Oncology
Opinion
August 21, 2019
Forging a path for gender equality in medicine
August 21, 2019
MDedge Hematology and Oncology
August 16, 2019
Legal duty to nonpatients: Driving accidents
August 16, 2019
MDedge Hematology and Oncology
July 17, 2019
Discovery of peer review and patient safety reports
July 17, 2019
MDedge Hematology and Oncology
